BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Laryngoscope, Trichostatin A, rs2230926, IL1A, T cell differentiation, Influenza)
Bookmark Forward

QuickView for XIAP (gene)


Body Atlas

Most Correlated Tissues

  1. Frontal cortex
  2. Spleen
  3. Prefrontal cortex
  4. Globus pallidum external
  5. Thyroid gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Other lymphoma
  2. Pyloric ulcer
  3. Disease due to Orthopoxvirus
  4. Injury of liver
  5. Dehydration
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Carotenoids
  2. dyclonine
  3. Hydrogen
  4. Butirosin Sulfate
  5. otoline
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Mcs5
  2. SAR1B
  3. TRIB2
  4. MGMT
  5. SAR1A
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
  2. Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key P…
  3. Ehrlichia Notch signaling induction promotes XIAP stability and inhibits apoptosis.
  4. XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6.
  5. Disruption of zinc (II) binding and dimeric protein structure of the XIAP-RING domain by copper (I) …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML
  2. Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
  3. Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
  4. Study of XIAP Antisense for Advanced Cancers
  5. XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carci…
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.